TransCon PTH

teriparatide · Ascendis Pharma A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TransCon PTH, covering 2023-09-01 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism [Phase 3]

See pricing